VEGF1 anticorps (N-Term)

N° du produit ABIN5539309

Cet anticorps anti-VEGF1 est un anticorps Lapin Polyclonal détectant VEGF1 dans WB. Adapté pour Humain.

Aperçu rapide pour VEGF1 anticorps (N-Term) (ABIN5539309)

Antigène: VEGF1 (PVF1) (PDGF and VEGF-Related Factor 1 (PVF1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp VEGF1 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-VEGF1 anticorps

Épitope: AA 66-95, N-Term

Purification: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis

Immunogène: This VEGF1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 66-95 amino acids from the N-terminal region of human VEGF1.

Isotype: Ig Fraction

Information d'application

Indications d'application: For WB starting dilution is: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 2 mg/mL

Buffer: Supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur VEGF1

Antigène: VEGF1 (PVF1) (PDGF and VEGF-Related Factor 1 (PVF1))

Autre désignation: VEGF1

Sujet: VEGF1 is a member of the PDGF/VEGF growth factor family and and is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein are linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in VEGF1 have been associated with proliferative and nonproliferative diabetic retinopathy.

Poids moléculaire: 27 kDa

ID gène: 7422

UniProt: P15692